On March 12, 2021, the inaugural meeting of the Special Committee on Heart Rhythm of Sichuan International Medical Exchange & Promotion Association (“SCIMEA”) was successfully held at the Renaissance ....
Now MedComm is privileged to have Prof. Günter P. Wagner, a U.S. Academician as an Editor-in-Chief.
On the morning, a meeting was held at the Great Hall of the People to commend role models in the country's fight against the COVID-19 epidemic.
On November 19, 2020, the “West China-Mayo International Forum of Critical Care Medicine 2020”, hosted by Sichuan Preventive Medicine Association, Sichuan International Medical Exchange & Promotion As
On December 10, the first Sichuan and Chongqing Science and Technology Academic Conference and Sichuan Science and Technology Academic Conference kicked off in Chengdu.
Chengdu High-Tech Zone, Shanghai Pharmaceuticals and Wesker sign an agreement to build Tianfu Vaccine Valley and create a full-chain vaccine industry
It is reported that the phase II clinical trial of the recombinant protein COVID-19 vaccine (Sf9 cell) from West China Hospital of Sichuan University/Chengdu Wesker Biomedical Co., Ltd.
On November 16, the signing ceremony for investment in Wesker, co-sponsored by Chengdu Wesker Biomedical Co., Ltd., Sichuan Development Holding Co., Ltd. and Shanghai Pharmaceuticals Holding Co., Ltd.
On August 28, 2020, the phase I clinical trial of the recombinant protein COVID-19 vaccine (Sf9 cell) of West China Hospital, Sichuan University kicked off its training effort in China Medical City